Skip to content

Complete Blood Count (CBC)

Published: August 9, 2026Updated: August 16, 2026

This test measures beta-amyloid proteins in cerebrospinal fluid to help evaluate for Alzheimer's disease and other neurodegenerative conditions.

Quick summary

{"Measures two types of beta-amyloid proteins (1-42 and 1-40) in spinal fluid","Helps doctors distinguish Alzheimer's disease from other types of dementia","Requires a lumbar puncture (spinal tap) to collect the sample","Lower 1-42 levels and specific ratios may indicate Alzheimer's disease","Results are used together with other clinical information for diagnosis"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
106057-3
Short code
AB42-40
Synonyms
Beta-Amyloid 1-42 and 1-40 pnl CSF
Category
chemistry
Sample
csf
Container
Polypropylene collection tubes (low-binding); transfer CSF to polypropylene cryovials after centrifugation; avoid polystyrene tubes which bind amyloid peptides and cause falsely low results.
Units
N/A
Ref low
1
Ref high
42
Fasting
false
Population
adult
Sex
all
Age range
≥ 21 years
Method
Chemiluminescent Immunoassay (CLIA) or Enzyme-Linked Immunosorbent Assay (ELISA)
CPT
83520 (x2 for Aβ1-42 and Aβ1-40)
SNOMED
39579001
Specimen volume
1-2 mL of CSF (3rd or 4th lumbar puncture fraction preferred); minimum 0.5 mL required for testing
Stability
Room temperature: 2 hours; Refrigerated (2-8°C): 14 days; Frozen at -20°C: 3 months; Frozen at -80°C: 12 months. Avoid repeated freeze-thaw cycles. Centrifuge sample prior to freezing if not analyzed immediately.
Hemolysis max
200
TAT
72–336 hours
Order
routine

A complete blood count, or CBC, is a common blood test that measures the different cells in your blood, including red blood cells, white blood cells, and platelets. It gives your doctor a broad picture of your overall health and can help detect a wide range of conditions.

The Beta-Amyloid 1-42 and 1-40 panel is a laboratory test that measures the levels of two specific proteins—beta-amyloid 1-42 and beta-amyloid 1-40—in your cerebrospinal fluid (CSF). CSF is the clear fluid that surrounds your brain and spinal cord. Beta-amyloid proteins are fragments of a larger protein that can clump together to form plaques in the brain, which are characteristic of Alzheimer's disease.

This test is performed to check your general health as part of a routine exam, or to help diagnose conditions such as anemia, infections, and blood disorders. It may also be ordered to monitor an existing medical condition or to see how a treatment, such as certain medications, is affecting your blood cells.

This test is primarily used to help diagnose Alzheimer's disease and distinguish it from other types of dementia or memory disorders. In Alzheimer's disease, the brain tends to produce less beta-amyloid 1-42, and this protein tends to accumulate into plaques rather than remaining in the CSF. The ratio of 1-42 to 1-40 is often more informative than either level alone. Your doctor may order this test if you are experiencing memory problems or cognitive decline and they want to understand the cause.

A sample is collected by drawing a small amount of blood from a vein, usually in your arm. A healthcare professional will clean the area, place a band around your upper arm, and insert a thin needle to collect the blood into a tube. The procedure takes only a few minutes, and you may feel a brief pinch.

The sample is collected through a procedure called a lumbar puncture, commonly known as a spinal tap. During this procedure, you will lie on your side or sit up, and a healthcare provider will insert a thin needle into the lower part of your spine to withdraw a small amount of CSF. The area will be numbed with local anesthetic to minimize discomfort. The procedure usually takes about 15-30 minutes, and you may be asked to lie flat for a short time afterward to reduce the chance of a headache.

Your results show whether your blood cell counts fall within the normal range. Low red blood cell counts may suggest anemia, while high white blood cell counts can point to an infection or inflammation. Abnormal platelet levels may affect clotting. Your doctor will interpret your results together with your symptoms and medical history to determine what they mean for you.

In Alzheimer's disease, beta-amyloid 1-42 levels in CSF are typically lower than normal because the protein aggregates into brain plaques instead of remaining in the CSF. The ratio of 1-42 to 1-40 is often reduced in Alzheimer's patients. However, it is important to understand that this test is not used alone to diagnose Alzheimer's disease—results are interpreted together with your symptoms, other test results, and clinical evaluation. Some patients with other neurological conditions may also show abnormal levels, so your doctor will consider the full picture.

Reference range

Beta-Amyloid 1-42: > 1025 pg/mL (varies by assay platform); Beta-Amyloid 1-40: typically > 6000 pg/mL; Beta-Amyloid 1-42/1-40 ratio: > 0.10 (ratio is the primary diagnostic parameter). Reference ranges vary significantly by laboratory and assay manufacturer; always interpret in conjunction with clinical findings.N/A

Specimen: csf

No fasting required. Lumbar puncture is typically performed in the morning. Patient should remain recumbent for at least 1 hour prior to procedure to reduce procedure-related complications. Inform physician of anticoagulant use, bleeding disorders, or active skin infection at puncture site.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Frequently asked questions

Is the lumbar puncture painful?
The procedure involves some discomfort, but the area is numbed with local anesthetic. You may feel a brief sting during the numbing injection, followed by pressure or a dull ache during the needle insertion. Most patients tolerate the procedure well. Some people may experience a headache afterward, which can usually be managed with rest and fluids.
How long does it take to get results?
Results are typically available within 1-2 weeks, but this may vary depending on the laboratory. Your healthcare provider will discuss the results with you at a follow-up appointment.
Can this test definitively diagnose Alzheimer's disease?
No, this test alone cannot definitively diagnose Alzheimer's disease. It is one piece of information that doctors use along with your medical history, cognitive tests, brain imaging, and other laboratory results to make a diagnosis. The test supports the clinical diagnosis but is not considered definitive.
Do I need to fast before this test?
No fasting is required for this test. You can eat and drink normally before the procedure. However, you should follow any specific instructions your healthcare provider gives you regarding medications or preparation.
Are there any risks after the lumbar puncture?
The most common side effect is a headache, which usually resolves within a few days. Drinking plenty of fluids and resting can help prevent or reduce the headache. Rare complications include infection, bleeding, or nerve irritation. Contact your healthcare provider if you experience severe headache, fever, stiff neck, or unusual symptoms after the procedure.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy